Sapien Stroke Discussion Continues With Expanded PARTNER Analysis
Investigators from Edwards Lifesciences’ PARTNER clinical trial reported a more detailed analysis of the incidence of stroke in study patients treated with the firm's Sapien transcatheter valve, though there did not appear to be any major new revelations that would impact approvability.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
